Results 211 to 220 of about 581,494 (309)

From Removal to Selective Control: Perspectives on Predation Management in Spanish Hunting Grounds. [PDF]

open access: yesAnimals (Basel)
Torres JA   +4 more
europepmc   +1 more source

Fight Like a Girl: Fitness Testing as Gendered Organizational Logic in the U.S. Army

open access: yesGender, Work &Organization, EarlyView.
ABSTRACT Organizational logics related to excellence and equity are changing rapidly in contemporary workplaces, yet limited research examines the impacts of specific policy initiatives, including why some fail—or even backfire. This study examines one such recent policy case: a temporary period of gender‐neutral fitness testing in the United States ...
Carrie Carter
wiley   +1 more source

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary This study shows that galcanezumab is equally effective and well‐tolerated in patients aged 65 and older as in younger patients, with a higher proportion of excellent responders in older patients. Despite having more baseline headache days, older patients responded well to the treatment, with age being linked to better outcomes ...
Julia Peris‐Subiza   +27 more
wiley   +1 more source

Relationship Between the Nurse-Patient Ratio and Adverse Events in Conventional Hospitalization Units in a Third-Level Hospital. [PDF]

open access: yesJ Nurs Manag
Fernández-Sánchez JD   +4 more
europepmc   +1 more source

Real‐world effectiveness and safety of galcanezumab for the treatment of migraine: A systematic review and meta‐analysis

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study aimed to summarize and pool real‐world evidence on the clinical effectiveness and safety of galcanezumab. Background Migraine is a disabling primary headache disorder. Several drugs that target calcitonin gene‐related peptide, such as galcanezumab, have recently been developed.
Jaime Fernández‐Bravo‐Rodrigo   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy